Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M611050200 on June 15, 2007 Originally published In Press as doi:10.1074/jbc.M611050200 on June 7, 2007

J. Biol. Chem., Vol. 282, Issue 31, 22707-22720, August 3, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/31/22707    most recent
M611050200v2
M611050200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jankowsky, J. L.
Right arrow Articles by Borchelt, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jankowsky, J. L.
Right arrow Articles by Borchelt, D. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Rodent Abeta Modulates the Solubility and Distribution of Amyloid Deposits in Transgenic Mice*

Joanna L. Jankowsky, Supported by the John Douglas French Alzheimer's Foundation and by NIA, National Institutes of Health Grant KO1 AG-26144-01{ddagger}1, Linda H. Younkin§, Victoria Gonzales, Daniel J. Fadale§, Hilda H. Slunt||, Henry A. Lester{ddagger}, Steven G. Younkin§, and David R. Borchelt||2

From the {ddagger}Division of Biology, California Institute of Technology, Pasadena, California 91125, the §Mayo Clinic Jacksonville, Jacksonville, Florida 32224, the Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, and the ||Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida 32610

The amino acid sequence of amyloid precursor protein (APP) is highly conserved, and age-related Abeta aggregates have been described in a variety of vertebrate animals, with the notable exception of mice and rats. Three amino acid substitutions distinguish mouse and human Abeta that might contribute to their differing properties in vivo. To examine the amyloidogenic potential of mouse Abeta, we studied several lines of transgenic mice overexpressing wild-type mouse amyloid precursor protein (moAPP) either alone or in conjunction with mutant PS1 (PS1dE9). Neither overexpression of moAPP alone nor co-expression with PS1dE9 caused mice to develop Alzheimer-type amyloid pathology by 24 months of age. We further tested whether mouse Abeta could accelerate the deposition of human Abeta by crossing the moAPP transgenic mice to a bigenic line expressing human APPswe with PS1dE9. The triple transgenic animals (moAPP x APPswe/PS1dE9) produced 20% more Abeta but formed amyloid deposits no faster and to no greater extent than APPswe/PS1dE9 siblings. Instead, the additional mouse Abeta increased the detergent solubility of accumulated amyloid and exacerbated amyloid deposition in the vasculature. These findings suggest that, although mouse Abeta does not influence the rate of amyloid formation, the incorporation of Abeta peptides with differing sequences alters the solubility and localization of the resulting aggregates.


Received for publication, November 30, 2006 , and in revised form, April 20, 2007.

* This work was supported in part by NIA, National Institutes of Health Grants 1 P50 AG-14-248 and 1 P01 AG-98-003 (to D. R. B.) and AG-06-656 (to S. G. Y.), the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program (to S. G. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence may be addressed: California Institute of Technology, M.C. 156-29, Pasadena, CA 91125. Tel.: 626-395-6884; Fax: 626-564-8709; E-mail: jlj2{at}caltech.edu. 2 To whom correspondence may be addressed: Dept. of Neuroscience, McKnight Brain Institute, University of Florida, 100 Newell Drive, Rm. L1-100H, P. O. Box 100244, Gainesville, FL 32610-0244. Tel.: 352-294-010; Fax: 352-392-8347; E-mail: borchelt{at}mbi.ufl.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement